Health

The European Union’s drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth ...

Britain reported record Covid-19 infections for the third consecutive day on Friday, with a rise to 93,045 new cases fuelled by the rapid spread of the Omicron variant of the virus. ...

International healthcare and diagnostic services company Medicover has acquired a controlling stake in Cypriot biotechnology NIPD Genetics, according to a statement released by the two companies earlier this month. “This ...

Two doses of Pfizer-BioNTech’s Covid -19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of ...

As Europe starts vaccinating younger children, countries are pursuing very different strategies in what will be a major test of parents’ willingness to get their kids inoculated. One region in ...

By Nikolaos Kapitsinis, No one would describe 2020 as normal. The coronavirus disrupted travel, employment and livelihoods. It pushed countries into lockdown, forcing people to change how they lived. And it ...

Auditor general Odysseas Michaelides on Thursday accused the health insurance organisation (HIO) of violating the law and philosophy of Gesy, charges quickly denied by the HIO which insisted that it ...

Members of the House health committee on Thursday welcomed planned updates to the national cancer strategy that will include a national cancer institute and urged the state to step up ...

The World Health Organization’s (WHO) vaccine advisory panel recommends that people who are immunocompromised or received an inactivated vaccine should receive a booster dose of a Covid-19 shot, it ...

New Zealand plans to ban young people from ever buying cigarettes in their lifetime in one of the world’s toughest crackdowns on the tobacco industry, arguing that other efforts ...

By Ludwig Burger and Michael Erman BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory ...

The Omicron variant can partially evade protection from two doses of Pfizer and partner BioNTech’s COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute ...

British drugmaker GSK said on Tuesday its antibody-based Covid-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data ...

Future pandemics could be even more lethal than Covid-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the ...

The World Health Organization (WHO) urged countries to boost healthcare capacity and vaccinate their people to fight a surge in COVID-19 cases driven by the Omicron variant, and said travel ...

Concluding our series on men’s health, Dr Chris Michael summarises the steps men need to take in all stages of their adult life Teens The teenage years are a ...

Roughly one in every 100 patients hospitalized with COVID-19 will likely have central nervous system complications, researchers reported this week at the annual meeting of the Radiological Society of North America . ...

A senior Botswana health official said on Tuesday that 16 out of the total 19 cases of the Omicron coronavirus variant detected in the country were asymptomatic, and it was “unfair” to ...

The European Union-wide rollout of Pfizer and BioNTech’s COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany’s health ministry ...

The European Union’s health commissioner has urged governments to boost efforts to detect coronavirus mutations, as some lag behind even as the new Omicron variant is detected around the ...

The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in ...

BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said ...

A new haemodialysis unit at Paphos general hospital is expected to be ready in October next year, as construction work progressed as scheduled, the unit’s director Lakis Yioukkas said ...

The Omicron coronavirus variant is likely to spread internationally, posing a “very high” global risk of infection surges that could have “severe consequences” some areas, the World Health Organisation (WHO) ...